MED12 and malignant colon neoplasm: Consistent with our results, MED12 loss could induce an EMT-like phenotype through activation of TGF-βR signaling pathway, which was associated with resistance to chemotherapy such as 5-FU and cisplatin in colon cancer patients [48].